机译:欧洲ALS患者的Ataxin-2中等长度多聚谷氨酰胺扩增
Department of Cell and Developmental Biology, the University of Pennsylvania School of Medicine, 1109 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA,;
Department of Cell and Developmental Biology, the University of Pennsylvania School of Medicine, 1109 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA,;
Department of Neurology, Umeå University, Sweden,;
Neuromuscular Diseases Unit, Kantonspital St Gallen, St Gallen, Switzerland,|Department of Neurology, University Hospital Basel, Basel, Switzerland,;
Department of Neurology, University Hospital Bergmannsheil, Ruhr-University Bochum, Germany,;
The Rehabilitation Centre for Neuromuscular Diseases, Copenhagen, Denmark,;
Neuromuscular Unit, Instituto de Medicina Molecular-Faculty of Medicine, Lisbon, Portugal,;
Department of Neurology, Charité University Hospital, Berlin, Germany,;
Department of Neurology, Haukeland University Hospital, Bergen, Norway,;
Molecular Neurogenetics, Department of Neurology, Goethe University, Frankfurt am Main, Germany and;
Molecular Neurogenetics, Department of Neurology, Goethe University, Frankfurt am Main, Germany and;
Department of Biology, the Howard Hughes Medical Institute, the University of Pennslvania, Philadelphia, PA 19104, USA;
Department of Neurology, Umeå University, Sweden,|Department of Neurology, Ulm University, Ulm, Germany,;
机译:欧洲ALS患者中的Ataxin-2中等长度的聚谷氨酰胺扩增。
机译:模型有机体揭示了人类神经退行性疾病的见解:ataxin-2中等长度的聚谷氨酰胺扩增是ALS的危险因素。
机译:Ataxin-2中等长度的聚谷氨酰胺扩增与ALS风险增加相关
机译:在临床试验中控制患者-通过法律规范的技术实施来提高临床试验中患者的能力的欧洲倡议
机译:定义肌萎缩性侧索硬化症中紫杉素2多谷氨酰胺扩展的机制。
机译:欧洲ALS患者的Ataxin-2中等长度多聚谷氨酰胺扩增
机译:欧洲ALS患者的Ataxin-2中等长度多聚谷氨酰胺扩增